Dr.竜馬のやさしくわかる集中治療　内分泌・消化器編

I 内分泌

P.29 掲載の参考文献

1) Kitabchi AE, et al : Hyperglycemic crises in adult patients with diabetes. Diabetes Care, 32 : 1335-1343, 2009 [PMID 19564476]

 

P.33 掲載の参考文献

1) Umpierrez G & Freire AX : Abdominal pain in patients with hyperglycemic crises. J Crit Care, 17 : 63-67, 2002 [PMID 12040551]

 

2) Nyenwe EA, et al : Active use of cocaine : an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr Pract, 13 : 22-29, 2007 [PMID 17360297]

 

P.41 掲載の参考文献

1) Katz MA : Hyperglycemia-induced hyponatremia--calculation of expected serum sodium depression. N Engl J Med, 289 : 843-844, 1973 [PMID 4763428]

 

2) Hillier TA, et al : Hyponatremia : evaluating the correction factor for hyperglycemia. Am J Med, 106 : 399-403, 1999 [PMID 10225241]

 

3) Kitabchi AE & Nyenwe EA : Hyperglycemic crises in diabetes mellitus : diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin North Am, 35 : 725-751, viii, 2006 [PMID 17127143]

 

P.45 掲載の参考文献

1) Sheikh-Ali M, et al : Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care, 31 : 643-647, 2008 [PMID 18184896]

 

P.50 掲載の参考文献

1) Slovis CM, et al : Diabetic ketoacidosis and infection : leukocyte count and differential as early predictors of serious infection. Am J Emerg Med, 5 : 1-5, 1987 [PMID 3101715]

 

2) Nair S, et al : Association of diabetic ketoacidosis and acute pancreatitis : observations in 100 consecutive episodes of DKA. Am J Gastroenterol, 95 : 2795-2800, 2000 [PMID 11051350]

 

P.51 掲載の参考文献

1) Adrogue HJ, et al : Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore), 65 : 163-172, 1986 [PMID 3084904]

 

P.57 掲載の参考文献

1) Van Zyl DG, et al : Fluid management in diabetic-acidosis--Ringer's lactate versus normal sali ne : a randomized controlled trial. Q J M, 105 : 337- 343, 2012 [PMID 22109683]

 

2) Kitabchi AE, et al : The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med, 84 : 633-638, 1976 [PMID 820228]

 

3) Umpierrez GE, et al : Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis : a randomized controlled trial. Diabetes Care, 32 : 1164-1169, 2009 [PMID 19366972]

 

4) Kitabchi AE, et al : Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis? Diabetes Care, 31 : 2081-2085, 2008 [PMID 18694978]

 

5) Fisher JN & Kitabchi AE : A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab, 57 : 177-180, 1983 [PMID 6406531]

 

6) Wilson HK, et al : Phosphate therapy in diabetic ketoacidosis. Arch Intern Med, 142 : 517-520, 1982 [PMID 6802095]

 

P.58 掲載の参考文献

1) Kruse JA & Carlson RW : Rapid correction of hypokalemia using concentrated intravenous potassium chloride infusions. Arch Intern Med, 150 : 613-617, 1990 [PMID 2310280]

 

P.70 掲載の参考文献

1) Kitabchi AE, et al : Hyperglycemic crises in adult patients with diabetes. Diabetes Care, 32 : 1335-1343, 2009 [PMID 19564476]

 

P.72 掲載の参考文献

1) Morris LR, et al : Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med, 105 : 836-840, 1986 [PMID 3096181]

 

2) Hale PJ, et al : Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J (Clin Res Ed), 289 : 1035-1038, 1984 [PMID 6091840]

 

P.81 掲載の参考文献

1) Kitabchi AE & Nyenwe EA : Hyperglycemic crises in diabetes mellitus : diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin North Am, 35 : 725-751, viii, 2006 [PMID 17127143]

 

P.90 掲載の参考文献

1) Vlasselaers D, et al : Intensive insulin therapy for patients in paediatric intensive care : a prospective, randomised controlled study. Lancet, 373 : 547-556, 2009 [PMID 19176240]

 

2) Rivers E, et al : Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 345 : 1368-1377, 2001 [PMID 11794169]

 

3) van den Berghe G, et al : Intensive insulin therapy in critically ill patients. N Engl J Med, 345 : 1359-1367, 2001 [PMID 11794168]

 

4) Krinsley JS : Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc, 79 : 992-1000, 2004 [PMID 15301325]

 

5) Van den Berghe G, et al : Intensive insulin therapy in the medical ICU. N Engl J Med, 354 : 449-461, 2006 [PMID 16452557]

 

P.95 掲載の参考文献

1) Brunkhorst FM, et al : Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med, 358 : 125-139, 2008 [PMID 18184958]

 

2) Preiser JC, et al : A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units : the Glucontrol study. Intensive Care Med, 35 : 1738-1748, 2009 [PMID 19636533]

 

3) Finfer S, et al : Intensive versus conventional glucose control in critically ill patients. N Engl J Med, 360 : 1283-1297, 2009 [PMID 19318384]

 

4) Moghissi ES, et al : American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care, 32 : 1119-1131, 2009 [PMID 19429873]

 

5) Dellinger RP, et al : Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock : 2012. Cr it Care Med, 41 : 580- 637, 2013 [PMID 23353941]

 

6) Niven DJ, et al : Effect of published scientific evidence on glycemic control in adult intensive care units. JAMA Intern Med, 175 : 801-809, 2015 [PMID 25775163]

 

7) Finfer S, et al : Hypoglycemia and risk of death in critically ill patients. N Engl J Med, 367 : 1108-1118, 2012 [PMID 22992074]

 

8) Lanspa MJ, et al : Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes. Chest, 143 : 1226-1234, 2013 [PMID 23238456]

 

P.104 掲載の参考文献

1) Sternthal E, et al : Suppression of thyroid radioiodine uptake by various doses of stable iodide. N Engl J Med, 303 : 1083-1088, 1980 [PMID 7421914]

 

P.110 掲載の参考文献

1) Slag MF, et al : Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA, 245 : 43-45, 1981 [PMID 7431627]

 

1) Sakr Y, et al : Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesth, 98 : 775-784, 2007 [PMID 17478454]

 

2) Van den Berghe G, et al : Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropinreleasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab, 84 : 1311-1323, 1999 [PMID 10199772]

 

2) Bloos F, et al : Effect of sodium selenite administration and procalcitoninguided therapy on mortality in patients with severe sepsis or septic shock : a randomized clinical trial. JA M A Intern Med, 176 : 1266-1276, 2016 [PMID 27428731]

 

3) Brent GA & Hershman JM : Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab, 63 : 1-8, 1986 [PMID 3011834]

 

P.113 掲載の参考文献

1) Takala J, et al : Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med, 341 : 785-792, 1999 [PMID 10477776]

 

P.129 掲載の参考文献

1) Peres Bota D, et al : Body temperature alterations in the critically ill. Intensive Care Med, 30 : 811-816, 2004 [PMID 15127194]

 

2) Popoveniuc G, et al : A diagnostic scoring system for myxedema coma. Endocr Pract, 20 : 808-817, 2014 [PMID 24518183]

 

3) 林寛之 : わけあり電解質の落とし穴 Part2. レジデントノート, 14 (9) : 1797-1809, 2012

Medical*Online

4) Spa sovsk i G, et a l : C l i n ic a l pr act ice g u idel i ne on d iag no si s a nd t re at ment of hyponatraemia. Intensive Care Med, 40 : 320-331, 2014 [PMID 24562549]

 

P.131 掲載の参考文献

1) Singer M, et al : The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315 : 801-810, 2016 [PMID 26903338]

 

P.141 掲載の参考文献

1) Spasovski G, et al : Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med, 40 : 320-331, 2014 [PMID 24562549]

 

P.143 掲載の参考文献

1) Spasovski G, et al : Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med, 40 : 320-331, 2014 [PMID 24562549]

 

2) Adrogue HJ & Madias NE : Hyponatremia. N Engl J Med, 342 : 1581-1589, 2000 [PMID 10824078]

 

3) Mohmand HK, et al : Hypertonic saline for hyponatremia : risk of inadvertent overcorrection. Clin J Am Soc Nephrol, 2 : 1110-1117, 2007 [PMID 17913972]

 

P.149 掲載の参考文献

1) Rodriguez I, et al : Factors associated with mortality of patients with myxoedema coma : prospective study in 11 cases treated in a single institution. J Endocrinol, 180 : 347-350, 2004 [PMID 14765987]

 

2) Yamamoto T, et al : Factors associated with mortality of myxedema coma : report of eight cases and literature survey. Thyroid, 9 : 1167-1174, 1999 [PMID 10646654]

 

3) Klubo-Gwiezdzinska J & Wartofsky L : Thyroid emergencies. Med Clin North Am, 96 : 385-403, 2012 [PMID 22443982]

 

4) Arlot S, et al : Myxoedema coma : response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med, 17 : 16-18, 1991 [PMID 2037720]

 

5) Holvey DN, et al : Treatment of myxedema coma with intravenous thyroxine. Arch Intern Med, 113 : 89-96, 1964 [PMID 14067598]

 

P.158 掲載の参考文献

1) Rhodes A, et al : Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Intensive Care Med, 43 : 304-377, 2017 [PMID 28101605]

 

P.167 掲載の参考文献

1) Krieger DT, et al : Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab, 32 : 266-284, 1971 [PMID 4321505]

 

P.176 掲載の参考文献

1) Allolio B : Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol, 172 : R115-R124, 2015 [PMID 25288693]

 

P.180 掲載の参考文献

1) Bornstein SR, et al : Diagnosis and Treatment of Primary Adrenal Insufficiency : An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 101 : 364-389, 2016 [PMID 26760044]

 

P.194 掲載の参考文献

1) Vermes I, et al : Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients : possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab, 80 : 1238-1242, 1995 [PMID 7714094]

 

2) Boonen E, et al : Reduced cortisol metabolism during critical illness. N Engl J Med, 368 : 1477-1488, 2013 [PMID 23506003]

 

3) Marik PE, et al : Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients : consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med, 36 : 1937-1949, 2008 [PMID 18496365]

 

4) Annane D, et al : A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA, 283 : 1038-1045, 2000 [PMID 10697064]

 

5) Siraux V, et al : Relative adrenal insufficiency in patients with septic shock : comparison of low-dose and conventional corticotropin tests. Crit Care Med, 33 : 2479-2486, 2005 [PMID 16276169]

 

6) Hamrahian AH, et al : Measurements of serum free cortisol in critically ill patients. N Engl J Med, 350 : 1629-1638, 2004 [PMID 15084695]

 

7) Cohen J, et al : Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population. Intensive Care Med, 32 : 1901-1905, 2006 [PMID 17019540]

 

P.201 掲載の参考文献

1) Sprung CL, et al : The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med, 311 : 1137-1143, 1984 [PMID 6384785]

 

2) Bone RC, et al : A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med, 317 : 653- 658, 1987 [PMID 3306374]

 

3) Veterans Administration Systemic Sepsis Cooperative Study Group : Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med, 317 : 659-665, 1987 [PMID 2888017]

 

4) Annane D, et al : Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA, 288 : 862-871, 2002 [PMID 12186604]

 

5) Dellinger RP, et al : Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 32 : 858-873, 2004 [PMID 15090974]

 

6) Sprung CL, et al : Hydrocortisone therapy for patients with septic shock. N Engl J Med, 358 : 111-124, 2008 [PMID 18184957]

 

7) Rhodes A, et al : Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Intensive Care Med, 43 : 304-377, 2017 [PMID 28101605]

 

P.206 掲載の参考文献

1) Siemieniuk RA, et al : Corticosteroid therapy for patients hospitalized with communityacquired pneumonia : a systematic review and meta-analysis. Ann Intern Med, 163 : 519-528, 2015 [PMID 26258555]

 

2) Annane D, et al : Corticosteroid treatment and intensive insulin therapy for septic shock in adults : a randomized controlled trial. JAMA, 303 : 341-348, 2010 [PMID 20103758]

 

3) Keh D, et al : Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock : a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med, 167 : 512-520, 2003 [PMID 12426230]

 

4) Keh D, et al : Effect of hydrocortisone on development of shock among patients with severe sepsis : the HYPRESS randomized clinical trial. JAMA, 316 : 1775-1785, 2016 [PMID 27695824]

 

5) Singer M, et al : The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315 : 801-810, 2016 [PMID 26903338]

 

P.207 掲載の参考文献

1) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference : definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 20 : 864-874, 1992 [PMID 1597042]

 

2) Levy MM, et al : 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med, 29 : 530-538, 2003 [PMID 12664219]

 

3) Singer M, et al : The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315 : 801-810, 2016 [PMID 26903338]

 

II 消化器

P.216 掲載の参考文献

1) Mutschler M, et al : The ATLS(R) classification of hypovolaemic shock : A well established teaching tool on the edge? Injury, 45S : S35-38, 2014 [PMID 25284231]

 

P.217 掲載の参考文献

1) Semler MW, et al : Flash mob research : a single-day, multicenter, resident-directed study of respiratory rate. Chest, 143 : 1740-1744, 2013 [PMID 23197319]

 

P.222 掲載の参考文献

1) De Backer D, et al : Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med, 362 : 779-789, 2010 [PMID 20200382]

 

P.229 掲載の参考文献

1) Holst LB, et al : Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med, 371 : 1381-1391, 2014 [PMID 25270275]

 

1) Caironi P, et al : Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med, 370 : 1412-1421, 2014 [PMID 24635772]

 

2) Annane D, et al : Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock : the CRISTAL randomized trial. JAMA, 310 : 1809-1817, 2013 [PMID 24108515]

 

2) Rhodes A, et al : Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Intensive Care Med, 43 : 304-377, 2017 [PMID 28101605]

 

3) Vincent JL, et al : Anemia and blood transfusion in critically ill patients. JAMA, 288 : 1499-1507, 2002 [PMID 12243637]

 

4) Rivers E, et al : Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 345 : 1368-1377, 2001 [PMID 11794169]

 

5) Hebert PC, et al : A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med, 340 : 409- 417, 1999 [PMID 9971864]

 

6) Villanueva C, et al : Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med, 368 : 11-21, 2013 [PMID 23281973]

 

P.230 掲載の参考文献

1) Ding YY, et al : Hemoglobin level and hospital mortality among ICU patients with cardiac disease who received transfusions. J Am Coll Cardiol, 66 : 2510-2518, 2015 [PMID 26653625]

 

1) Lacroix J, et al : Age of transfused blood in critically ill adults. N Engl J Med, 372 : 1410-1418, 2015 [PMID 25853745]

 

2) Heddle NM, et al : Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. N Engl J Med, 375 : 1937-1945, 2016 [PMID 27775503

 

P.237 掲載の参考文献

1) Strate LL & Gralnek IM : ACG Clinical Guideline : Management of patients with acute lower gastrointestinal bleeding. Am J Gastroenterol, 111 : 459-474, 2016 [PMID 26925883]

 

2) Srygley FD, et al : Does this patient have a severe upper gastrointestinal bleed? JAMA, 307 : 1072-1079, 2012 [PMID 22416103]

 

3) Aljebreen AM, et al : Nasogastric aspirate predicts high-risk endoscopic lesions in patients with acute upper-GI bleeding. Gastrointest Endosc, 59 : 172-178, 2004 [PMID 14745388]

 

4) Huang ES, et al : Impact of nasogastric lavage on outcomes in acute GI bleeding. Gastrointest Endosc, 74 : 971-980, 2011 [PMID 21737077]

 

5) Pateron D, et al : Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding : a multicenter randomized controlled trial. Ann Emerg Med, 57 : 582-589, 2011 [PMID 21333385]

PubMed

6) Laine L & Jensen DM : Management of patients with ulcer bleeding. Am J Gastroenterol, 107 : 345-360 ; quiz 361, 2012 [PMID 22310222]

 

7) Gralnek IM, et al : Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage : European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 47 : a1-46, 2015 [PMID 26417980]

 

8) Ponsky JL, et al : Saline irrigation in gastric hemorrhage : the effect of temperature. J Surg Res, 28 : 204-205, 1980 [PMID 6990109]

 

P.244 掲載の参考文献

1) Laine L : CLINICAL PRACTICE. Upper gastrointestinal bleeding due to a peptic ulcer. N Engl J Med, 374 : 2367-2376, 2016 [PMID 27305194]

 

2) Mallory GK & Weiss S : Hemorrhages from lacerations of the cardiac orifice of the stomach due to vomiting. Am J Med Sci, 178 : 506-515, 1929

 

3) Eloubeidi MA & El Majzoub NW : Images in clinical medicine. Duodenal Dieulafoy's lesion. N Engl J Med, 367 : e6, 2012 [PMID 22830483]

 

4) Savides TJ, et al : Severe upper gastrointestinal tumor bleeding : endoscopic findings, treatment, and outcome. Endoscopy, 28 : 244-248, 1996 [PMID 8739741]

 

P.251 掲載の参考文献

1) Narum S, et al : Corticosteroids and risk of gastrointestinal bleeding : a systematic review and meta-analysis. BMJ Open, 4 : e004587, 2014 [PMID 24833682]

 

2) Kanno T, et al : Peptic ulcers after the Great East Japan earthquake and tsunami : possible existence of psychosocial stress ulcers in humans. J Gastroenterol. 48 : 483-490, 2013 [PMID 23053423]

 

P.257 掲載の参考文献

1) Hwang JH, et al : The role of endoscopy in the management of acute non-variceal upper GI bleeding. Gastrointest Endosc, 75 : 1132-1138, 2012 [PMID 22624808]

 

2) Blatchford O, et al : A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet, 356 : 1318-1321, 2000 [PMID 11073021]

 

3) Laine L : CLINICAL PRACTICE. Upper gastrointestinal bleeding due to a peptic ulcer. N Engl J Med, 374 : 2367-2376, 2016 [PMID 27305194]

 

4) Laursen SB, et al : Performance of new thresholds of the Glasgow Blatchford score in managing patients with upper gastrointestinal bleeding. Clin Gastroenterol Hepatol, 13 : 115-l21.e2, 2015 [PMID 25058843]

 

5) Stanley AJ, et al : Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding : international multicentre prospective study. BMJ, 356 : Published online 2017 Jan 4 [PMID 28053181]

 

6) Lin HJ, et al : Early or delayed endoscopy for patients with peptic ulcer bleeding. A prospective randomized study. J Clin Gastroenterol, 22 : 267-271, 1996 [PMID 8771420]

 

7) Lim LG, et al : Urgent endoscopy is associated with lower mortality in high-risk but not low-risk nonvariceal upper gastrointestinal bleeding. Endoscopy, 43 : 300-306, 2011 [PMID 21360421]

PubMed

P.264 掲載の参考文献

1) Lanzon-Miller S, et al : Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther, 1 : 239-251, 1987 [PMID 2979226]

 

2) Levine JE, et al : Meta-analysis : the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther, 16 : 1137-1142, 2002 [PMID 12030956]

 

3) Leontiadis GI, et al : Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ, 330 : 568, 2005 [PMID 15684023]

 

4) Hwang JH, et al : The role of endoscopy in the management of acute non-variceal upper GI bleeding. Gastrointest Endosc, 75 : 1132-1138, 2012 [PMID 22624808]

 

5) Gralnek IM, et al : Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage : European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 47 : a1-46, 2015 [PMID 26417980]

 

6) Laine L & Jensen DM : Management of patients with ulcer bleeding. Am J Gastroenterol, 107 : 345-360 ; quiz 361, 2012 [PMID 22310222]

 

7) Barkun AN, et al : International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med, 152 : 101-113, 2010 [PMID 20083829]

 

8) National Clinical Guideline Centre (UK). Acute Upper Gastrointestinal Bleeding : Management. NICE Clinical Guidelines, 141, 2012 [PMID 25340230]

 

9) Sachar H, et al : Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers : a systematic review and meta-analysis. JAMA Intern Med, 174 : 1755-1762, 2014 [PMID 25201154]

 

10) Sung JJ, et al : Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy. Am J Gastroenterol, 109 : 1005-1010, 2014 [PMID 24777150]

 

11) Bai Y, et al : Meta-analysis : erythromycin before endoscopy for acute upper gastrointestinal bleeding. Aliment Pharmacol Ther, 34 : 166-171, 2011 [PMID 21615438]

 

12) Shakur H, et al : Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) : a randomised, placebo-controlled trial. Lancet, 376 : 23-32, 2010 [PMID 20554319]

 

13) Bennett C, et al : Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev, : CD006640, 2014 [PMID 25414987]

 

P.265 掲載の参考文献

1) Neuman MD, et al : Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations. JAMA, 311 : 2092-2100, 2014 [PMID 24867012]

 

2) Shojania KG, et al : How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med, 147 : 224-233, 2007 [PMID 17638714]

 

3) Dellinger RP, et al : Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 32 : 858-873, 2004 [PMID 15090974]

 

4) Dellinger RP, et al : Surviving Sepsis Campaign : international guidelines for management of severe sepsis and septic shock : 2008. Crit Care Med, 36 : 296-327, 2008 [PMID 18158437]

 

5) Dellinger RP, et al : Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock : 2012. Crit Care Med, 41 : 580-637, 2013 [PMID 23353941]

 

P.273 掲載の参考文献

1) Forrest JA, et al : Endoscopy in gastrointestinal bleeding. Lancet, 2 : 394-397, 1974 [PMID 4136718]

 

2) Laine L & Jensen DM : Management of patients with ulcer bleeding. Am J Gastroenterol, 107 : 345-360, 2012 [PMID 22310222]

 

3) Muguruma N, et al : Endoscopic Management of Nonvariceal Upper Gastrointestinal Bleeding : state of the Art. Clin Endosc, 48 : 96-101, 2015

PubMed

4) Gralnek IM, et al : Management of acute bleeding from a peptic ulcer. N Engl J Med, 359 : 928-937, 2008 [PMID 18753649]

 

5) El Ouali S, et al : Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis : a systematic review. Can J Gastroenterol Hepatol, 28 : 543-548, 2014 [PMID 25390616]

 

6) Lau JY, et al : Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med, 340 : 751-756, 1999 [PMID 10072409]

 

P.279 掲載の参考文献

1) Cheng HC, et al : Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients : a randomised controlled study. Gut, 63 : 1864-1872, 2014 [PMID 24658598]

 

2) Guirguis-Blake JM, et al : Aspirin for the Primary Prevention of Cardiovascular Events : A Systematic Evidence Review for the U. S. Preventive Services Task Force. Ann Intern Med, 164 : 804-813, 2016 [PMID 27064410]

 

3) Antithrombotic Trialists' Collaboration : Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 324 : 71-86, 2002 [PMID 11786451]

 

4) Sung JJ, et al : Continuation of low-dose aspirin therapy in peptic ulcer bleeding : a randomized trial. Ann Intern Med, 152 : 1-9, 2010 [PMID 19949136]

 

5) Laine L & Jensen DM : Management of patients with ulcer bleeding. Am J Gastroenterol, 107 : 345-360 ; quiz 361, 2012 [PMID 22310222]

 

6) Gralnek IM, et al : Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage : European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 47 : a1-46, 2015 [PMID 26417980]

 

7) Chan FK, et al : Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med, 347 : 2104-2110, 2002 [PMID 12501222]

 

8) Chan FK, et al : Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk : a double-blind, randomised trial. Lancet, 369 : 1621-1626, 2007 [PMID 17499604]

 

9) Gisbert JP, et al : Meta-analysis : Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther, 19 : 617-629, 2004 [PMID 15023164]

 

10) Wong GL, et al : High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology, 137 : 525-531, 2009 [PMID 19445937]

 

P.290 掲載の参考文献

1) Skillman JJ & Silen W : Acute gastroduodenal "stress" ulceration : barrier disruption of varied pathogenesis? Gastroenterology, 59 : 478-482, 1970 [PMID 5458292]

 

2) Peura DA & Johnson LF : Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med, 103 : 173-177, 1985 [PMID 3874573]

 

3) Shuman RB, et al : Prophylactic therapy for stress ulcer bleeding : a reappraisal. Ann Intern Med, 106 : 562-567, 1987 [PMID 3548524]

 

4) ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm, 56 : 347-379, 1999 [PMID 10690219]

 

5) Dellinger RP, et al : Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock : 2012. Cr it Care Med, 41 : 580- 637, 2013 [PMID 23353941]

 

6) Cook DJ, et al : Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med, 330 : 377-381, 1994 [PMID 8284001]

 

7) Krag M, et al : Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med, 41 : 833-845, 2015 [PMID 25860444]

 

8) Cook D, et al : A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med, 338 : 791-797, 1998 [PMID 9504939]

 

9) Alhazzani W, et al : Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients : a systematic review and meta-analysis. Crit Care Med, 41 : 693-705, 2013 [PMID 23318494]

 

10) MacLaren R, et al : Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med, 174 : 564-574, 2014 [PMID 24535015]

 

11) Barletta JF, et al : Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care, 29 : 955-960, 2014 [PMID 25081626]

 

12) Marik PE, et al : Stress ulcer prophylaxis in the new millennium : a systematic review and meta-analysis. Crit Care Med, 38 : 2222-2228, 2010 [PMID 20711074]

 

13) Krag M, et al : Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med, 40 : 11-22, 2014 [PMID 24141808]

 

14) Selvanderan SP, et al : Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP) : Randomized Double-Blind Exploratory Study. Crit Care Med, 44 : 1842-1850, 2016 [PMID 27635481]

PubMed

P.294 掲載の参考文献

1) Wade EE, et al : H (2) antagonist-induced thrombocytopenia : is this a real phenomenon? Intensive Care Med, 28 : 459-465, 2002 [PMID 11967601]

 

1) Miranda RC & Schaffner DW : Longer Contact Times Increase Cross-Contamination of Enterobacter aerogenes from Surfaces to Food. Appl Environ Microbiol, 82 : 6490-6496, 2016 [PMID 27590818]

 

2) MacLaren R, et al : Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med, 174 : 564-574, 2014 [PMID 24535015]

 

3) Alhazzani W, et al : Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients : a systematic review and meta-analysis. Crit Care Med, 41 : 693-705, 2013 [PMID 23318494]

 

4) Faleck DM, et al : Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit. Am J Gastroenterol, 111 : 1641-1648, 2016 [PMID 27575714]

 

5) MacLaren R & Campbell J : Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*. Crit Care Med, 42 : 809-815, 2014 [PMID 24365863]

 

6) Farley KJ, et al : Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting. Crit Care Resusc, 15 : 147-151, 2013 [PMID 23961576]

 

P.308 掲載の参考文献

1) Yang PM & Chen DS : Images in clinical medicine. Caput medusae. N Engl J Med, 353 : e19, 2005 [PMID 16306514]

 

P.310 掲載の参考文献

1) Swanson KL, et al : Natural history of hepatopulmonary syndrome : Impact of liver transplantation. Hepatology, 41 : 1122-1129, 2005 [PMID 15828054]

 

P.317 掲載の参考文献

1) Vlavianos P, et al : Splanchnic and systemic haemody namic response to volume changes in patients with cirrhosis and portal hypertension. Clin Sci (Lond), 96 : 475-481, 1999 [PMID 10209079]

 

2) Villanueva C, et al : Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med, 368 : 11-21, 2013 [PMID 23281973]

 

3) Tripathi D, et al : U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut, 64 : 1680-1704, 2015 [PMID 25887380]

 

4) Ge PS & Runyon BA : Serum ammonia level for the evaluation of hepatic encephalopathy. JAMA, 312 : 643-644, 2014 [PMID 25117134]

 

5) Soares-Weiser K, et al : Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev, : CD002907, 2002 [PMID 12076458]

 

6) Chavez-Tapia NC, et al : Meta-analysis : antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-an updated Cochrane review. Aliment Pharmacol Ther, 34 : 509-518, 2011 [PMID 21707680]

 

7) Fernandez J, et al : Norf loxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology, 131 : 1049-1056 ; quiz 1285, 2006 [PMID 17030175]

 

P.324 掲載の参考文献

1) Hsu YC, et al : Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol, 24 : 1294-1299, 2009 [PMID 19682197]

 

2) Moitinho E, et al : Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology, 117 : 626-631, 1999 [PMID 10464138]

 

3) Garcia-Tsao G & Bosch J : Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med, 362 : 823-832, 2010 [PMID 20200386]

 

4) Pugh RN, et al : Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 60 : 646-649, 1973 [PMID 4541913]

 

5) Abraldes JG, et al : Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol, 48 : 229-236, 2008 [PMID 18093686]

 

6) Garcia-Pagan JC, et al : Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med, 362 : 2370-2379, 2010 [PMID 20573925]

 

7) Reverter E, et al : A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology, 146 : 412-419. e 3, 2014 [PMID 24148622]

 

P.327 掲載の参考文献

1) Connors AF Jr, et al : The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA, 276 : 889-897, 1996 [PMID 8782638]

 

2) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, et al : Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med, 354 : 2213-2224, 2006 [PMID 16714768]

 

P.332 掲載の参考文献

1) National Clinical Guideline Centre (UK) : Acute Upper Gastrointestinal Bleeding : Management. Royal College of Physicians (UK), 2012 [PMID 25340230]

 

2) Garcia-Tsao G, et al : Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology, 46 : 922-938, 2007 [PMID 17879356]

 

3) Hwang JH, et al : The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc, 80 : 221-227, 2014 [PMID 25034836]

 

4) Tripathi D, et al : U. K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut, 64 : 1680-1704, 2015 [PMID 25887380]

 

5) de Franchis R : Expanding consensus in portal hypertension : Report of the Baveno VI Consensus Workshop : Stratifying risk and individualizing care for portal hypertension. J Hepatol, 63 : 743-752, 2015 [PMID 26047908]

 

6) Ioannou G, et al : Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev, : CD002147, 2003 [PMID 12535432]

 

7) Seo YS, et al : Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology, 60 : 954-963, 2014 [PMID 24415445]

 

8) Lebrec D, et al : Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis : a controlled study. N Engl J Med, 305 : 1371-1374, 1981 [PMID 7029276]

 

9) Pascal JP & Cales P : Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med, 317 : 856-861, 1987 [PMID 3306385]

 

P.334 掲載の参考文献

1) Landry DW, et al : Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation, 95 : 1122-1125, 1997 [PMID 9054839]

 

2) Russell JA, et al : Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med, 358 : 877-887, 2008 [PMID 18305265]

 

3) Gordon AC, et al : Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock : the VANISH randomized clinical trial. JAMA, 316 : 509-518, 2016 [PMID 27483065]

 

4) Rhodes A, et al : Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Intensive Care Med, 43 : 304-377, 2017 [PMID 28101605]

 

P.335 掲載の参考文献

1) Groszmann RJ, et al : Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med, 353 : 2254-2261, 2005 [PMID 16306522]

 

2) Llach J, et al : Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology, 94 : 482-487, 1988 [PMID 3335320]

 

3) de Franchis R : Expanding consensus in portal hypertension : Report of the Baveno VI Consensus Workshop : Stratifying risk and individualizing care for portal hypertension. J Hepatol, 63 : 743-752, 2015 [PMID 26047908]

 

4) Krag A, et al : The window hypothesis : haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease. Gut, 61 : 967-969, 2012 [PMID 22234982]

 

P.338 掲載の参考文献

1) Torrazza-Perez E & Carreno N : Images in clinical medicine. Bleeding esophageal varices. N Engl J Med, 362 : e13, 2010 [PMID 20130251]

 

2) Laine L & Cook D : Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med, 123 : 280-287, 1995 [PMID 7611595]

 

P.344 掲載の参考文献

1) Sanyal AJ, et al : Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology, 111 : 138-146, 1996 [PMID 8698192]

 

2) Monescillo A, et al : Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology, 40 : 793-801, 2004 [PMID 15382120]

 

3) Garcia-Pagan JC, et al : Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med, 362 : 2370-2379, 2010 [PMID 20573925]

 

P.351 掲載の参考文献

1) Bircher J, et al : Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet, 1 : 890-892, 1966 [PMID 4159616]

 

2) Elkington SG, et al : Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. N Engl J Med, 281 : 408-412, 1969 [PMID 4894464]

 

3) Als-Nielsen B, et al : Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev, : CD003044, 2004 [PMID 15106187]

 

4) Sharma BC, et al : A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol, 108 : 1458-1463, 2013 [PMID 23877348]

 

5) Plauth M, et al : ESPEN Guidelines on Enteral Nutrition : Liver disease. Clin Nutr, 25 : 285-294, 2006 [PMID 16707194]

 

6) Cordoba J, et al : Normal protein diet for episodic hepatic encephalopathy : results of a randomized study. J Hepatol, 41 : 38-43, 2004 [PMID 15246205]

 

7) Gluud LL, et al : Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials. J Nutr, 143 : 1263-1268, 2013 [PMID 23739310]

 

8) Naylor CD, et al : Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology, 97 : 1033-1042, 1989 [PMID 2506095]

 

P.361 掲載の参考文献

1) Valette X & du Cheyron D : IM AGES IN CL INICA L MEDICIN E. Cullen's and Grey Turner's Signs in Acute Pancreatitis. N Engl J Med, 373 : e28, 2015 [PMID 26650175]

 

2) Working Group IAP/APA Acute Pancreatitis Guidelines : IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology, 13 : e1-15, 2013 [PMID 24054878]

 

P.368 掲載の参考文献

1) Tenner S, et al : Predicting gallstone pancreatitis with laboratory parameters : a metaanalysis. Am J Gastroenterol, 89 : 1863-1866, 1994 [PMID 7942684]

 

2) Badalov N, et al : Drug-induced acute pancreatitis : an evidence-based review. Clin Gastroenterol Hepatol, 5 : 648-661 ; quiz 644, 2007 [PMID 17395548]

 

3) Fan JH, et al : Updated meta-analysis of pancreatic stent placement in preventing postendoscopic retrograde cholangiopancreatography pancreatitis. World J Gastroenterol, 21 : 7577-7583, 2015 [PMID 26140006]

 

4) Sethi S, et al : A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas, 43 : 190-197, 2014 [PMID 24518496]

 

P.374 掲載の参考文献

1) Banks PA, et al : Classification of acute pancreatitis--2012 : revision of the Atlanta classification and definitions by international consensus. Gut, 62 : 102-111, 2013 [PMID 23100216]

 

2) Bradley EL 3rd : A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg, 128 : 586-590, 1993 [PMID 8489394]

 

P.379 掲載の参考文献

1) Tenner S, et al : American College of Gastroenterology guideline : management of acute pancreatitis. Am J Gastroenterol, 108 : 1400-1415, 2013 [PMID 23896955]

 

2) Ranson JH, et al : Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet, 139 : 69-81, 1974 [PMID 4834279]

 

3) Knaus WA, et al : APACHE II : a severity of disease classification system. Crit Care Med, 13 : 818-829, 1985 [PMID 3928249]

 

4) Di MY, et al : Prediction models of mortality in acute pancreatitis in adults : a systematic review. Ann Intern Med, 165 : 482-490, 2016 [PMID 27454310]

 

5) Working Group IAP/APA Acute Pancreatitis Guidelines : IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology, 13 : e1-15, 2013 [PMID 24054878]

 

6) Mofidi R, et al : Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg, 93 : 738-744, 2006 [PMID 16671062]

 

7) Bollen TL, et al : A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol, 107 : 612-619, 2012 [PMID 22186977]

 

8) Ranson JH, et al : Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet, 143 : 209-219, 1976 [PMID 941075]

 

P.381 掲載の参考文献

1) Bone RC, et al : Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101 : 1644-1655, 1992 [PMID 1303622]

 

2) Singer M, et al : The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315 : 801-810, 2016 [PMID 26903338]

 

P.386 掲載の参考文献

1) Wall I, et al : Decreased mortality in acute pancreatitis related to early aggressive hydration. Pancreas, 40 : 547-550, 2011 [PMID 21499208]

 

2) de-Madaria E, et al : Influence of fluid therapy on the prognosis of acute pancreatitis : a prospective cohort study. Am J Gastroenterol, 106 : 1843-1850, 2011 [PMID 21876561]

 

3) Wu BU, et al : Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol, 9 : 710-717. e1, 2011 [PMID 21645639]

 

4) Du XJ, et al : Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis. Pancreas, 40 : 1220-1225, 2011 [PMID 21775917]

 

5) Perner A, et al : Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med, 367 : 124-134, 2012 [PMID 22738085]

 

6) Helm JF, et al : Effects of morphine on the human sphincter of Oddi. Gut, 29 : 1402-1407, 1988 [PMID 3197985]

 

7) Basurto Ona X, et al : Opioids for acute pancreatitis pain. Cochrane Database Syst Rev, CD009179, 2013 [PMID 23888429]

 

P.388 掲載の参考文献

1) The Acute Respiratory Distress Syndrome Network : Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med, 342 : 1301-1308, 2000 [PMID 10793162]

 

2) Villanueva C, et al : Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med, 368 : 11-21, 2013 [PMID 23281973]

 

P.391 掲載の参考文献

1) Zarychanski R, et al : Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation : a systematic review and meta-analysis. JAMA, 309 : 678-688, 2013 [PMID 23423413]

 

2) Perner A, et al : Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med, 367 : 124-134, 2012 [PMID 22738085]

 

P.396 掲載の参考文献

1) Li J, et al : Early oral refeeding wisdom in patients with mild acute pancreatitis. Pancreas, 42 : 88-91, 2013 [PMID 22836861]

 

2) Al-Omran M, et al : Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev, CD002837, 2010 [PMID 20091534]

 

3) Bakker OJ, et al : Early versus on-demand nasoenteric tube feeding in acute pancreatitis. N Engl J Med, 371 : 1983-1993, 2014 [PMID 25409371]

 

4) Petrov MS, et al : Systematic review and meta-analysis of enteral nutrition formulations in acute pancreatitis. Br J Surg, 96 : 1243-1252, 2009 [PMID 19847860]

 

5) Singh N, et al : Evaluation of early enteral feeding through nasogastric and nasojejunal tube in severe acute pancreatitis : a noninferiority randomized controlled trial. Pancreas, 41 : 153-159, 2012 [PMID 21775915]

 

6) Eatock FC, et al : A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol, 100 : 432-439, 2005 [PMID 15667504]

 

P.401 掲載の参考文献

1) 急性膵炎診療ガイドライン 2015 第4版 (急性膵炎診療ガイドライン 2015 改訂出版委員会/編), 金原出版, 2015

 

2) Seta T, et al : Treatment of acute pancreatitis with protease inhibitors administered through intravenous infusion : an updated systematic review and meta-analysis. BMC Gastroenterol, 14 : 102, 2014 [PMID 24886242]

 

3) Yasunaga H, et al : Effect and cost of treatment for acute pancreatitis with or without gabexate mesylate : a propensity score analysis using a nationwide administrative database. Pancreas, 42 : 260-264, 2013 [PMID 23000890]

 

4) Piascik M, et al : The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic : a randomized controlled study. Pancreas, 39 : 863-867, 2010 [PMID 20431422]

 

5) Horibe M, et al : Continuous regional arterial infusion of protease inhibitors has no efficacy in the treatment of severe acute pancreatitis : a retrospective multicenter cohort study. Pancreas, 46 : 510-517, 2017 [PMID 27977624]

 

6) Folsch UR, et al : Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med, 336 : 237-242, 1997 [PMID 8995085]

 

7) Tse F & Yuan Y : Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitis. Cochrane Database Syst Rev, CD009779, 2012 [PMID 22592743]

 

8) Fogel EL & Sherman S : ERCP for gallstone pancreatitis. N Engl J Med, 370 : 150-157, 2014 [PMID 24401052]

 

P.407 掲載の参考文献

1) 「急性膵炎診療ガイドライン 2015 第4版」 (急性膵炎診療ガイドライン 2015改訂出版委員会/編), 金原出版, 2015

 

P.413 掲載の参考文献

1) Lim CL, et al : Role of antibiotic prophylaxis in necrotizing pancreatitis : a meta-analysis. J Gastrointest Surg, 19 : 480-491, 2015 [PMID 25608671]

 

2) Villatoro E, et al : Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev, : CD002941, 2010 [PMID 20464721]

 

3) Tenner S, et al : American College of Gastroenterology guideline : management of acute pancreatitis. Am J Gastroenterol, 108 : 1400-15 ; 1416, 2013 [PMID 23896955]

 

4) Working Group IAP/APA Acute Pancreatitis Guidelines : IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology, 13 : e1-15, 2013 [PMID 24054878]

 

5) Rhodes A, et al : Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Intensive Care Med, 43 : 304-377, 2017 [PMID 28101605]

 

6) Lumsden A & Bradley EL 3rd : Secondary pancreatic infections. Surg Gynecol Obstet, 170 : 459-467, 1990 [PMID 2183376]

 

7) Freeman ML, et al : Interventions for necrotizing pancreatitis : summary of a multidisciplinary consensus conference. Pancreas, 41 : 1176-1194, 2012 [PMID 23086243]

 

8) van Santvoort HC, et al : Videoscopic assisted retroperitoneal debridement in infected necrotizing pancreatitis. HPB (Oxford), 9 : 156-159, 2007 [PMID 18333133]

 

9) van Santvoort HC, et al : A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med, 362 : 1491-1502, 2010 [PMID 20410514]

 

10) Bakker OJ, et al : Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis : a randomized trial. JAMA, 307 : 1053-1061, 2012 [PMID 22416101]

 

P.417 掲載の参考文献

1) van Baal MC, et al : Timing of cholecystectomy after mild biliary pancreatitis : a systematic review. Ann Surg, 255 : 860-866, 2012 [PMID 22470079]

 

2) da Costa DW, et al : Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO) : a multicentre randomised controlled trial. Lancet, 386 : 1261-1268, 2015 [PMID 26460661]

 

3) Nealon WH, et al : Appropriate timing of cholecystectomy in patients who present with moderate to severe gallstone-associated acute pancreatitis with peripancreatic fluid collections. Ann Surg, 239 : 741-749 ; discussion 749-751, 2004 [PMID 15166953]

 

書評を投稿する